| 000 | 01830 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518033431.0 | ||
| 264 | 0 | _c20190812 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1528-3658 | ||
| 024 | 7 |
_a10.1186/s10020-019-0081-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Huan | |
| 245 | 0 | 0 |
_aInhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation. _h[electronic resource] |
| 260 |
_bMolecular medicine (Cambridge, Mass.) _c04 2019 |
||
| 300 |
_a13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCholinergic Agonists _xpharmacology |
| 650 | 0 | 4 |
_aEndocytosis _xdrug effects |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aHMGB1 Protein _xmetabolism |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 | _aRAW 264.7 Cells |
| 650 | 0 | 4 |
_aReceptor for Advanced Glycation End Products _xmetabolism |
| 700 | 1 | _aLiu, Hui | |
| 700 | 1 | _aZeng, Qiong | |
| 700 | 1 | _aImperato, Gavin H | |
| 700 | 1 | _aAddorisio, Meghan E | |
| 700 | 1 | _aLi, Jianhua | |
| 700 | 1 | _aHe, Mingzhu | |
| 700 | 1 | _aCheng, Kai Fan | |
| 700 | 1 | _aAl-Abed, Yousef | |
| 700 | 1 | _aHarris, Helena E | |
| 700 | 1 | _aChavan, Sangeeta S | |
| 700 | 1 | _aAndersson, Ulf | |
| 700 | 1 | _aTracey, Kevin J | |
| 773 | 0 |
_tMolecular medicine (Cambridge, Mass.) _gvol. 25 _gno. 1 _gp. 13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s10020-019-0081-6 _zAvailable from publisher's website |
| 999 |
_c29578870 _d29578870 |
||